UQ Expert Joins Global Consensus On World's Deadliest Diseases, Australia
Main Category: Public HealthAlso Included In: Cardiovascular / Cardiology; Respiratory / Asthma; Diabetes
Article Date: 23 Nov 2007 - 1:00 PST
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
A University of Queensland professor is among the panel of world leading health scientists who have reached consensus on the world's most deadly diseases.
Professor Alan Lopez of UQ's School of Population Health is part of a committee of leading health experts that has declared chronic non-communicable diseases (CNCDs) to be reaching global epidemic proportions, accounting for more than 60% of deaths worldwide. Their findings are published this week in the pre-eminent Nature journal.
CNCDs include cardiovascular disease, type 2 diabetes, chronic respiratory diseases and certain cancers. Most, says Professor Lopez, have been proven to be largely preventable.
"Healthy diet, physical activity and not smoking prevent about 80% of heart disease, strokes and type 2 diabetes and over 40% of cancer cases," he said.
In the Nature paper, the group of scientists name 20 top priorities ('grand challenges') that must be acted upon to restrain and reverse the growing incidence of CNCDs.
They include raising the political priority of non-communicable diseases, promoting healthy lifestyle choices, addressing the impact of government spending and taxation on health, investigating the effectiveness of food labelling legislation and identifying the negative impacts of economic growth on health.
Professor Lopez, who co-authored the World Health Organisation's seminal Global Burden of Disease study, said the committee hopes to galvanise the world's political, medical and scientific leaders into taking real action on CNCDs.
"We expect the burden from CNCDs to rise quickly over the next few decades, particularly in the developing world," he said.
"But with concerted action taken now, we can avert at least 36 million premature deaths by 2015."
The 20 Grand Challenges complement the 'Grand Challenges in Health' published in 2003 by the Bill and Melinda Gates Foundation, an organisation established to help reduce inequities in health around the world.
Professor Lopez and UQ colleagues are working closely with the Foundation on various global initiatives, including the Monitoring Vital Events (MoVE) project to analyse the lack or inadequacy of civil registration systems for counting births, deaths, and causes of death. MoVE is supported by the Health Metrics Network (HMN), which receives major funding from the Gates Foundation. The School of Population Health has strong links with the Network and is currently shortlisted, with partner Jane Thomason International, to become a global HMN Technical Resource Centre.
The Nature paper can be read in full here.
The University of Queensland, Brisbane Australia
Visit our public health section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/89681.php>
APA
http://www.medicalnewstoday.com/releases/89681.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





